Australia's Vaxxas secures ~A$90 M in funding to commercialise needle-free vaccination delivery technology

Australia-based Vaxxas Pty Ltd, the biotechnology company pioneering the high-density microarray patch (HD-MAP) for need...

August 26, 2025 | Tuesday | News
SK Bioscience evaluates partnership with Gates Foundation for next-gen preventive medicines

SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cu...

August 22, 2025 | Friday | News
Australia's CSL announces demerger of vaccines arm

Australian biotech firm CSL has announced its intention for CSL Seqirus to be demerged as a substantial ASX-listed entit...

August 20, 2025 | Wednesday | News
Singapore approves Beyfortus® (nirsevimab) to protect all infants against RSV disease

The Health Sciences Authority (HSA) has approved Sanofi and AstraZeneca’s BEYFORTUS (nirsevimab) for the preventio...

August 19, 2025 | Tuesday | News
Leading science labs in Korea join world’s largest vaccine testing network

Two leading scientific organisations based in Korea, the Korea Disease Control and Prevention Agency (KDCA) and Int...

August 6, 2025 | Wednesday | News
UK supports world-first library of vaccine-enhancing adjuvants

Scientists have launched the first-ever library of adjuvants - substances that could boost the performance of vaccines t...

August 4, 2025 | Monday | News
Korea's Dx&Vx signs $220 M agreement for mRNA cancer vaccine development with US biotech firm

South Korea-based Dx&Vx (DXVX) has signed its first-ever global out-licensing agreement since its establishment. DXV...

July 30, 2025 | Wednesday | News
Korea's International Vaccine Institute opens collaboration centre in Bhutan

The Bhutan-International Vaccine Institute (IVI) Collaborating Centre has been officially launched in Thimphu, Bhutan, m...

July 25, 2025 | Friday | News
Sanofi to acquire Vicebio, expanding respiratory vaccines pipeline

Sanofi has entered into an agreement to acquire Vicebio Ltd, a privately held biotechnology company headquartered in Lon...

July 23, 2025 | Wednesday | News
New project in Australia to support faster approvals of vaccines

Australian scientists will kickstart research into how early vaccine studies can safely support faster approvals of vacc...

July 23, 2025 | Wednesday | News
New drug research partnership aims to deliver $1 malaria prevention shot

Eyam Health and Medicines for Malaria Venture (MMV) are excited to announce a strategic research partnership to discover...

July 22, 2025 | Tuesday | News
Shanghai Healthcare M&A Fund strategically acquires Chengdu Kanghua Biological

Chengdu Kanghua Biological Products Co. has announced that Shanghai Healthcare M&A Fund intends to acquire the compa...

July 22, 2025 | Tuesday | News
GC Biopharma receives marketing authorisation for varicella vaccine BARYCELA in Vietnam

GC Biopharma, a South Korean pharmaceutical company, has announced that its varicella vaccine BARYCELA has received mark...

July 17, 2025 | Thursday | News
Japan's Next-generation 'nanoball' approach strives for a paradigm shift in vaccine technology

(From Left to Right) Professor Kouichi Morita, Dean, Program Coordinator, Institute of Tropical Medicine, Nagasaki Un...

July 16, 2025 | Wednesday | Opinion
Korea's IVI forges partnership with Bio Investments Group to accelerate vaccine self-reliance in Africa and the Middle East

The Bio Investments Group AG (BIG), a Swiss healthcare-technology transfer platform, and South Korea-headquartered Inter...

July 11, 2025 | Friday | News
Indian biopharma firm Biological E partners with China's Recbio to produce HPV9 vaccine

Jiangsu Recbio Technology, a leading Chinese biopharmaceutical company, has entered into a licensing cooperation agreeme...

July 2, 2025 | Wednesday | News
SK bioscience completes expansion of new vaccine production facility in South Korea for global market

SK bioscience, a global innovative vaccine and biotech company based in South Korea, has secured a large-scale co...

June 30, 2025 | Monday | News
Singapore pledges contribution of $1 M to Gavi for better access to vaccines

Singapore has pledged a contribution of $1 million to Gavi, the Vaccine Alliance (Gavi). This reflects Singapore&rsquo...

June 26, 2025 | Thursday | News